wpadmin

MassTech Awarded Phase II SBIRs

On 1 June 2011, MassTech was notified of award for two Phase 2 Small Business Innovation Research grants, totalling $1.35M. The projects (NASA Proposal A3.02-8812 and Navy (NAVAIR) N8335) deal with LIDAR analysis of wind and turbulence. This makes a total of four Phase 2 SBIR grants awarded to MassTech within the past two years.

Read More

SESI to Participate in Team Selected by NASA for European Space Agency ExoMars Mission

On 8 January 2007, a team led by the University of California at Santa Barbara was selected by NASA for delivery of the Mars Organic Molecule Analyzer (MOMA). Intended for the European Space Agency ExoMars mission in 2013, MOMA will analyze organic molecular signatures and the environment in which they exist. SESI’s contribution will be delivery of a specialized AP/MALDI mass spectrometry ion source and miniature tandem Mass Spectrometer. (NASA press release)

Read More

Science & Engineering Services Awarded Wide-Spectrum Bio-ID Contract

On 19 September 2006, SESI was awarded a $4.0M contract by the US Army RDECOM Acquisition Center under the Joint PEO for Chemical and Biological Defense. The award is for Phase II development of Wide-Spectrum Bio-ID, a broadband approach for rapid detection and identification of biological agents through integration of proteomics, atmospheric pressure (AP) matrix assisted laser desorption/ionization (MALDI) tandem mass spectrometry (MS/MS), and bio-informatics. Key partners include University of Maryland at College Park, Signature Science, and SAIC-EAI.

Read More

MassTech Signs Agreement With Agilent Technologies

MassTech Inc., a provider of AP-MALDI technology for mass spectrometry, and Agilent Technologies today announced that it has signed an agreement to distribute AP/MALDI and AP/MALDI-PDF ion sources. Terms of the agreement have not been released. More information about the G1972 and G1974 AP/MALDI ion sources can be found in the Products section.

Read More

MassTech Introduces Atmospheric Pressure MALDI Source (AP/MALDI) for Thermo Finnigan™ LTQ™ and LTQ FT™ Mass Spectrometers

MassTech Inc., a provider of AP-MALDI technology for mass spectrometry, today announced the availability of AP/MALDI-PDF ion sources for Thermo Finnigan’s linear ion trap (Finnigan™ LTQ™) and hybrid LIT (Finnigan™ LTQ FT™) mass spectrometers. The AP/MALDI-PDF ion source can be switched with electrospray in just minutes. The AP/MALDI-PDF is designed for tool-less, rapid attachment to the LTQ without the need to break vacuum. The larger square source housing accommodates ABI sample plates, and integrates pulsed dynamic focusing (PDF) technology which…

Read More

MassTech Signs Co-Marketing Agreement With Applied Biosystems/MDS SCIEX

MassTech Inc., a provider of AP-MALDI technology for mass spectrometry, and Applied Biosystems/MDS SCIEX, a joint-venture between Applied Biosystems Group (NYSE: ABI) an Applera Corporation Business, and MDS Inc. (TSE:MDS; NYSE: MDZ), today announced that it has signed an agreement to market the MassTech AP/MALDI system as a front end ion source for the AB/MDS SCIEX 4000 Q TRAP® LC/MS/MS. The collaboration brings MALDI capabilities to the 4000 Q TRAP® LC/MS/MS platform to facilitate metabolite identification and post-translational modification identification.…

Read More

MassTech To Develop an Atmospheric Pressure MALDI Source (AP/MALDI) for the 4000 Q TRAP® LC/MS/MS system of Applied Biosystems/MDS SCIEX

MassTech Inc., a provider of AP-MALDI technology for mass spectrometry today announced that it will develop an Atmospheric Pressure Matrix-Assisted Laser Desorption/Ionization (AP/MALDI) ion source for the 4000 Q TRAP® LC/MS/MS System with the assistance of Applied Biosystems/MDS SCIEX. Applied Biosystems/MDS SCIEX, the manufacturer of the 4000 Q TRAP® system, is a joint venture between Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and MDS Inc. (TSE:MDS; NYSE:MDZ). The 4000 Q TRAP® system is used during most stages of drug…

Read More